irinotecan,leucovorin,oxaliplatin,nab-paclitaxel,gemcitabine
Ipsen
[]
ipsen presents phase iii napoli 3 trial of onivyde regimen demonstrating positive survival results in previously untreated metastatic pancreatic ductal adenocarcinoma at asco gi 
Pharmaceutical News - Direct Information